$2.97
+0.06 (+2.06%)
Open$2.83
Previous Close$2.91
Day High$2.98
Day Low$2.78
52W High$9.50
52W Low$1.98
Volume—
Avg Volume16.5K
Market Cap34.08M
P/E Ratio—
EPS$-0.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,389.2% upside
Current
$2.97
$2.97
Target
$44.23
$44.23
$32.29
$44.23 avg
$55.91
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.90M | 15.57M | 15.33M |
| Net Income | 2.99M | 2.88M | 3.11M |
| Profit Margin | 17.7% | 18.5% | 20.3% |
| EBITDA | 3.97M | 4.34M | 3.61M |
| Free Cash Flow | 3.54M | 3.27M | 3.55M |
| Rev Growth | +19.1% | +9.8% | -6.9% |
| Debt/Equity | 0.36 | 0.34 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |